Income Statement SpectraCure AB

Stocks

SPEC

SE0007158118

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 04:42:18 2026-08-12 EDT			5-day change	1st Jan Change
0.0399 ^SEK	+2.05%		+9.02%	-74.39%

07-16	Calendar, Thursday, July 16	FW
06-18	Boule Diagnostics appoints Johan Folkunger as new CEO	FW

de6b5dbba00dcf6ab8143a8ddf4b9.vC7ybkZpX_-RKum-8pwbnDh4gMaOgZT0kyBu0bFHnvc.9V_BCBFRJ4vlbrrJpdNdy24y6I3-xaej501Ynccf-ZLzZpkkBwA2uP9arA

Published financial data: SPECTRACURE AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	-	-
Other Revenues, Total	1.61M	-	318K	-	-
Total Revenues	1.61M	-	318K	-	-
Cost of Goods Sold, Total	-1.38M	-3.05M	-9.54M	-9.77M	-12.44M
Gross Profit	2.99M	3.05M	9.86M	9.77M	12.44M
Selling General & Admin Expenses, Total	27.76M	28.72M	30.91M	31.62M	36.66M
Depreciation & Amortization - (IS)	2.67M	2.87M	2.66M	2.64M	30.14M
Other Operating Expenses	-4.11M	-2.82M	-2.24M	-1.39M	908K
Other Operating Expenses, Total	26.31M	28.77M	31.33M	32.86M	67.7M
Operating Income	-23.32M	-25.73M	-21.47M	-23.1M	-55.26M
Interest Expense, Total	-245K	-182K	-522K	-469K	-1.25M
Interest And Investment Income	216K	537K	1.95M	1.21M	229K
Net Interest Expenses	-29K	355K	1.42M	738K	-1.02M
Income (Loss) On Equity Invest.	-	-	-536K	-694K	-
Currency Exchange Gains (Loss)	-	-	-	40K	234K
Other Non Operating Income (Expenses)	-	-	-	1K	-
EBT, Excl. Unusual Items	-23.35M	-25.37M	-20.58M	-23.01M	-56.05M
Gain (Loss) On Sale Of Assets	1K	53K	123K	-	-
Asset Writedown	-	-60K	-	-	-
EBT, Incl. Unusual Items	-23.35M	-25.38M	-20.46M	-23.01M	-56.05M
Income Tax Expense	-5K	-	-21K	-7K	27K
Earnings From Continuing Operations	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Net Income to Company	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Net Income - (IS)	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Net Income to Common Incl Extra Items	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Net Income to Common Excl. Extra Items	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Per Share Items
Net EPS - Basic	-0.24	-0.26	-0.21	-0.24	-0.2
Basic EPS - Continuing Operations	-0.24	-0.26	-0.21	-0.24	-0.2
Basic Weighted Average Shares Outstanding	97.13M	97.13M	97.13M	97.13M	283M
Net EPS - Diluted	-0.24	-0.26	-0.21	-0.24	-0.2
Diluted EPS - Continuing Operations	-0.24	-0.26	-0.21	-0.24	-0.2
Diluted Weighted Average Shares Outstanding	97.13M	97.13M	97.13M	97.13M	283M
Normalized Basic EPS	-0.15	-0.16	-0.13	-0.15	-0.12
Normalized Diluted EPS	-0.15	-0.16	-0.13	-0.15	-0.12
Supplemental Items
EBITDA	-22.86M	-25.22M	-20.97M	-22.68M	-54.92M
EBITA	-23.14M	-25.51M	-21.26M	-22.88M	-55.06M
EBIT	-23.32M	-25.73M	-21.47M	-23.1M	-55.26M
EBITDAR	-22.86M	-25.22M	-20.97M	-22.68M	-54.92M
Total Revenues (As Reported)	5.75M	2.94M	2.84M	1.53M	868K
Effective Tax Rate - (Ratio)	0.02	-	0.1	0.03	-0.05
Total Current Taxes	-5K	-	-	-	-
Total Deferred Taxes	-	-	-21K	-7K	27K
Normalized Net Income	-14.59M	-15.86M	-12.87M	-14.38M	-35.03M
Interest on Long-Term Debt	243K	177K	520K	463K	307K
Supplemental Operating Expense Items
Net Rental Expense, Total	0	0	0	0	0
Imputed Operating Lease Interest Expense	0	0	0	0	0
Imputed Operating Lease Depreciation	0	0	0	0	0

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	130M	93.18M	56.95M	18.27M	13.52M
Total Cash And Short Term Investments	130M	93.18M	56.95M	18.27M	13.52M
Accounts Receivable, Total	193K	146K	183K	328K	598K
Other Receivables	910K	1.02M	1.62M	3.64M	1.96M
Total Receivables	1.1M	1.16M	1.8M	3.97M	2.56M
Prepaid Expenses	-	-	-	-	105K
Other Current Assets, Total	-	-	-	-	35K
Total Current Assets	131M	94.34M	58.75M	22.25M	16.22M
Gross Property Plant And Equipment	-	-	-	7.02M	4.67M
Accumulated Depreciation	-	-	-	-1.62M	-1.62M
Net Property Plant And Equipment	6.18M	3.96M	6.95M	5.4M	3.05M
Long-term Investments	-	1.23M	694K	-	-
Other Intangibles, Total	1.19M	1.18M	1.23M	1.38M	1.64M
Deferred Tax Assets Long-Term	21K	21K	21K	7K	-
Deferred Charges Long-Term	52.34M	61.68M	77.19M	91.97M	83.56M
Total Assets	191M	162M	145M	121M	104M
Liabilities
Accounts Payable, Total	1.83M	1.61M	1.04M	3.32M	1.71M
Accrued Expenses, Total	3.06M	3.09M	2.37M	2.2M	6M
Current Portion of Leases	2.41M	2.43M	2.32M	2.54M	2.57M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	1.96M	1.22M	575K	51K	172K
Other Current Liabilities	3.09M	3.5M	4.28M	3.43M	219K
Total Current Liabilities	12.35M	11.85M	10.58M	11.54M	10.67M
Long-Term Leases	2.49M	270K	4.4M	2.6M	218K
Deferred Tax Liability Non Current	-	-	-	-	25K
Total Liabilities	14.84M	12.12M	14.98M	14.15M	10.92M
Common Stock, Total	9.71M	9.71M	9.71M	9.71M	40.97M
Additional Paid In Capital	258M	258M	258M	258M	268M
Retained Earnings	-92.05M	-117M	-138M	-161M	-215M
Comprehensive Income and Other	-	1K	-	-	-
Total Common Equity	176M	150M	130M	107M	93.55M
Total Equity	176M	150M	130M	107M	93.55M
Total Liabilities And Equity	191M	162M	145M	121M	104M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	97.13M	97.13M	97.13M	97.13M	410M
ECS Total Common Shares Outstanding	97.13M	97.13M	97.13M	97.13M	410M
Book Value / Share	1.81	1.55	1.34	1.1	0.23
Tangible Book Value	174M	149M	129M	105M	91.91M
Tangible Book Value Per Share	1.8	1.54	1.32	1.09	0.22
Total Debt	4.9M	2.7M	6.72M	5.14M	2.79M
Net Debt	-125M	-90.48M	-50.23M	-13.13M	-10.74M
Debt Equivalent Oper. Leases	0	0	0	0	0
Equity Method Investments, Total	-	1.23M	694K	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	1.86M	1.73M
Full Time Employees	17	16	16	16	13

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-23.34M	-25.38M	-20.44M	-23M	-56.08M
Depreciation & Amortization - CF	2.44M	2.67M	2.4M	2.4M	2.34M
Amortization of Goodwill and Intangible Assets - (CF)	175K	213K	218K	218K	204K
Depreciation & Amortization, Total	2.62M	2.88M	2.61M	2.62M	2.55M
Amortization of Deferred Charges, Total - (CF)	48K	49K	49K	16K	-
(Gain) Loss on Sale of Investments - (CF)	-	-	536K	694K	-
Asset Writedown & Restructuring Costs	-	60K	-	-	-
Other Operating Activities, Total	-67K	-32K	186K	-130K	30.13M
Change In Accounts Receivable	100K	-25K	-462K	-2.06M	274K
Change in Other Net Operating Assets	2.04M	-518K	-1.16M	744K	-899K
Cash from Operations	-18.6M	-22.96M	-18.68M	-21.12M	-24.03M
Capital Expenditure	-164K	-559K	-	-130K	-
Sale of Property, Plant, and Equipment	-	-	205K	-	-
Sale (Purchase) of Intangible assets	-8.33M	-9.56M	-15.77M	-15.15M	-19.64M
Investment in Marketable and Equity Securities, Total	-	-1.23M	-	-	-
Cash from Investing	-8.49M	-11.35M	-15.56M	-15.28M	-19.64M
Short Term Debt Issued, Total	-	-	-	-	15.62M
Total Debt Issued	-	-	-	-	15.62M
Short Term Debt Repaid, Total	-	-	-	-	-15.62M
Long-Term Debt Repaid, Total	-2.26M	-2.2M	-1.99M	-2.28M	-2.36M
Total Debt Repaid	-2.26M	-2.2M	-1.99M	-2.28M	-17.98M
Issuance of Common Stock	-	-	-	-	54.76M
Other Financing Activities, Total	1.8M	-	-	-	-13.48M
Cash from Financing	-453K	-2.2M	-1.99M	-2.28M	38.92M
Net Change in Cash	-27.55M	-36.51M	-36.23M	-38.68M	-4.75M
Supplemental Items
Cash Income Tax Paid (Refund)	85K	35K	174K	116K	290K
Levered Free Cash Flow	-18.5M	-23.96M	-28.65M	-28.8M	-52.04M
Unlevered Free Cash Flow	-18.35M	-23.84M	-28.32M	-28.51M	-51.26M
Change In Net Working Capital	-2.05M	577K	1.8M	1.43M	-374K
Net Debt Issued / Repaid	-2.26M	-2.2M	-1.99M	-2.28M	-2.36M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-7.27	-9.11	-8.74	-10.86	-30.64
Return on Total Capital	-7.61	-9.64	-9.27	-11.61	-33.16
Return On Equity %	-12.52	-15.57	-14.59	-19.44	-55.97
Return on Common Equity	-12.52	-15.57	-14.59	-19.44	-55.97
Margin Analysis
Gross Profit Margin %	186.13	-	3.1K	-	-
SG&A Margin	1.73K	-	9.72K	-	-
EBITDA Margin %	-1.42K	-	-6.59K	-	-
EBITA Margin %	-1.44K	-	-6.68K	-	-
EBIT Margin %	-1.45K	-	-6.75K	-	-
Income From Continuing Operations Margin %	-1.45K	-	-6.43K	-	-
Net Income Margin %	-1.45K	-	-6.43K	-	-
Net Avail. For Common Margin %	-1.45K	-	-6.43K	-	-
Normalized Net Income Margin	-907.45	-	-4.05K	-	-
Levered Free Cash Flow Margin	-1.15K	-	-9.01K	-	-
Unlevered Free Cash Flow Margin	-1.14K	-	-8.91K	-	-
Asset Turnover
Asset Turnover	0.01	-	0	-	-
Fixed Assets Turnover	0.25	-	0.06	-	-
Receivables Turnover (Average Receivables)	-	-	-	-	-
Short Term Liquidity
Current Ratio	10.59	7.96	5.55	1.93	1.52
Quick Ratio	10.59	7.96	5.55	1.93	1.51
Operating Cash Flow to Current Liabilities	-1.51	-1.94	-1.77	-1.83	-2.25
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Average Days Payable Outstanding	-381.08	-205.93	-50.63	-81.61	-73.74
Long Term Solvency
Total Debt/Equity	2.79	1.8	5.17	4.81	2.98
Total Debt / Total Capital	2.72	1.76	4.92	4.59	2.89
LT Debt/Equity	1.42	0.18	3.39	2.44	0.23
Long-Term Debt / Total Capital	1.38	0.18	3.22	2.32	0.23
Total Liabilities / Total Assets	7.79	7.46	10.34	11.69	10.45
EBIT / Interest Expense	-95.18	-141.36	-41.14	-49.25	-44.07
EBITDA / Interest Expense	-84.49	-125.52	-36.13	-43.66	-42.04
(EBITDA - Capex) / Interest Expense	-85.16	-128.59	-36.13	-43.94	-42.04
Total Debt / EBITDA	-0.24	-0.12	-0.36	-0.25	-0.05
Net Debt / EBITDA	6.03	3.96	2.66	0.64	0.2
Total Debt / (EBITDA - Capex)	-0.23	-0.12	-0.36	-0.25	-0.05
Net Debt / (EBITDA - Capex)	5.98	3.87	2.66	0.64	0.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.78	-	-41	-	-
Gross Profit, 1 Yr. Growth %	-15.95	119.93	175.01	2.36	27.39
EBITDA, 1 Yr. Growth %	53.14	10.27	-16.72	7.85	142.2
EBITA, 1 Yr. Growth %	52.64	10.21	-16.56	7.33	140.65
EBIT, 1 Yr. Growth %	52.22	10.29	-16.41	7.26	139.27
Earnings From Cont. Operations, 1 Yr. Growth %	51.5	8.73	-19.46	12.54	143.78
Net Income, 1 Yr. Growth %	51.5	8.73	-19.46	12.54	143.78
Normalized Net Income, 1 Yr. Growth %	51.24	8.64	-18.75	11.79	143.59
Diluted EPS Before Extra, 1 Yr. Growth %	41.35	8.73	-19.46	14.04	-16.41
Accounts Receivable, 1 Yr. Growth %	-42.56	-24.35	25.34	79.23	82.32
Net Property, Plant and Equip., 1 Yr. Growth %	-7.96	-35.93	75.69	-22.29	-43.58
Total Assets, 1 Yr. Growth %	-9.51	-14.75	-10.83	-16.45	-13.66
Tangible Book Value, 1 Yr. Growth %	-11.04	-14.54	-13.74	-18	-12.86
Common Equity, 1 Yr. Growth %	-10.92	-14.45	-13.6	-17.71	-12.45
Cash From Operations, 1 Yr. Growth %	97.84	23.43	-18.65	13.06	13.76
Capital Expenditures, 1 Yr. Growth %	-62.39	240.85	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	28.83	29.47	19.72	0.41	80.68
Unlevered Free Cash Flow, 1 Yr. Growth %	29.32	29.93	18.92	0.53	79.79
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.17	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-5.9	-7.51	166.8	65.05	14.19
EBITDA, 2 Yr. CAGR %	31.25	29.97	-4.24	-5.09	61.62
EBITA, 2 Yr. CAGR %	31.27	29.72	-4.18	-5.24	60.72
EBIT, 2 Yr. CAGR %	31.11	29.59	-4.05	-5.18	60.2
Earnings From Cont. Operations, 2 Yr. CAGR %	30.6	28.34	-6.42	-4.79	65.63
Net Income, 2 Yr. CAGR %	30.6	28.34	-6.42	-4.79	65.63
Normalized Net Income, 2 Yr. CAGR %	30.58	28.2	-6.12	-4.7	65.01
Diluted EPS Before Extra, 2 Yr. CAGR %	20.27	23.97	-6.42	-4.16	-3.01
Accounts Receivable, 2 Yr. CAGR %	-1.27	-34.08	-2.63	49.89	80.77
Net Property, Plant and Equip., 2 Yr. CAGR %	-12.05	-23.21	6.09	16.85	-33.78
Total Assets, 2 Yr. CAGR %	37.9	-12.17	-12.81	-13.69	-15.07
Tangible Book Value, 2 Yr. CAGR %	41.8	-12.81	-14.14	-15.9	-15.47
Common Equity, 2 Yr. CAGR %	41.47	-12.7	-14.02	-15.68	-15.12
Cash From Operations, 2 Yr. CAGR %	36.02	56.27	0.21	-4.09	13.41
Capital Expenditures, 2 Yr. CAGR %	-57.78	13.23	-	-51.78	-
Levered Free Cash Flow, 2 Yr. CAGR %	-4.16	29.16	24.43	9.71	34.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.22	29.63	24.24	9.41	34.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	39.21	-	-35.96	-	-
Gross Profit, 3 Yr. CAGR %	-4.44	-3.41	40.42	91.76	51.4
EBITDA, 3 Yr. CAGR %	21.9	23.86	11.99	-0.28	29.69
EBITA, 3 Yr. CAGR %	22.16	23.85	11.92	-0.39	29.29
EBIT, 3 Yr. CAGR %	22.06	23.78	11.92	-0.33	29.09
Earnings From Cont. Operations, 3 Yr. CAGR %	22.13	22.86	9.88	-0.48	30.25
Net Income, 3 Yr. CAGR %	22.13	22.86	9.88	-0.48	30.25
Normalized Net Income, 3 Yr. CAGR %	22.14	22.83	10.07	-0.49	30.31
Diluted EPS Before Extra, 3 Yr. CAGR %	13.37	16.29	7.37	-0.04	-8.83
Accounts Receivable, 3 Yr. CAGR %	145.78	-9.66	-18.33	19.34	60
Net Property, Plant and Equip., 3 Yr. CAGR %	260.38	-20.87	1.19	-4.36	-8.33
Total Assets, 3 Yr. CAGR %	40.33	17.47	-11.72	-14.04	-13.68
Tangible Book Value, 3 Yr. CAGR %	39.69	19.77	-13.12	-15.45	-14.9
Common Equity, 3 Yr. CAGR %	39.35	19.64	-13	-15.27	-14.62
Cash From Operations, 3 Yr. CAGR %	15.86	31.69	25.71	4.32	1.52
Capital Expenditures, 3 Yr. CAGR %	-	-15.3	-	-7.45	-
Levered Free Cash Flow, 3 Yr. CAGR %	-1.86	5.95	25.89	15.9	29.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.13	6.03	25.92	15.82	29.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-14.12	-	-11.81	-	-
Gross Profit, 5 Yr. CAGR %	17.96	10.94	23.52	23.64	28.43
EBITDA, 5 Yr. CAGR %	27.9	24.17	10.68	11.31	29.76
EBITA, 5 Yr. CAGR %	28.08	24.28	10.86	11.24	29.42
EBIT, 5 Yr. CAGR %	27.89	24.22	10.86	11.23	29.25
Earnings From Cont. Operations, 5 Yr. CAGR %	29.65	23.89	9.79	10.95	29.48
Net Income, 5 Yr. CAGR %	29.65	23.89	9.79	10.95	29.48
Normalized Net Income, 5 Yr. CAGR %	29.65	23.88	9.95	10.94	29.42
Diluted EPS Before Extra, 5 Yr. CAGR %	16.37	11.2	5	7.63	3.09
Accounts Receivable, 5 Yr. CAGR %	98.58	101.34	69.71	10.62	12.22
Net Property, Plant and Equip., 5 Yr. CAGR %	119.56	82.84	120.97	-7.52	-14.6
Total Assets, 5 Yr. CAGR %	45.95	61.66	16	3.85	-13.08
Tangible Book Value, 5 Yr. CAGR %	52.17	63.76	14.98	3.98	-14.07
Common Equity, 5 Yr. CAGR %	51.37	62.15	14.87	4.01	-13.86
Cash From Operations, 5 Yr. CAGR %	-1.03	29.41	9.32	16	20.64
Capital Expenditures, 5 Yr. CAGR %	-	33.1	-	-32.39	-
Levered Free Cash Flow, 5 Yr. CAGR %	-2.78	35.95	7.92	7.42	29.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.91	35.82	7.67	7.35	29.29